AngioDynamics Q3 Adjusted EPS $(0.16) Misses $(0.13) Estimate, Sales $75.18M Miss $75.73M Estimate
Portfolio Pulse from Benzinga Newsdesk
AngioDynamics reported Q3 adjusted EPS of $(0.16), missing the $(0.13) estimate, and sales of $75.18M, missing the $75.73M estimate. This represents a significant decrease in performance compared to the same period last year.
April 04, 2024 | 11:02 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
AngioDynamics reported a larger than expected quarterly loss and a miss in sales estimates, indicating a significant decrease in performance from the previous year.
The reported earnings miss and sales miss are likely to negatively impact investor sentiment in the short term. The significant decrease in performance compared to the same period last year further exacerbates concerns, likely leading to a decrease in stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100